Cellular Biomedicine Group Inc (CBMG) Expands GMP Capacity For The Growing Chinese Market

Cellular Biomedicine Group Inc (NASDAQ:CBMG) is a developer of proprietary cell therapies for the treatment of cancer and other degenerative diseases, which operates in China. The biomedicine firm has...... (read more)